Millennium Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-138,224
Closed -$1.55M 6643
2025
Q2
$1.55M Sell
138,224
-1,972,550
-93% -$11.2M ﹤0.01% 4090
2025
Q1
$9.65M Sell
2,110,774
-1,808,357
-46% -$12.1M 0.01% 2235
2024
Q4
$22.1M Sell
3,919,131
-1,044,050
-21% -$5.89M 0.02% 1442
2024
Q3
$24M Buy
4,963,181
+1,092,341
+28% +$6.34M 0.02% 1380
2024
Q2
$18.9M Buy
3,870,840
+3,256,410
+530% +$20.5M 0.02% 1547
2024
Q1
$8.16M Buy
+614,430
New +$8.15M 0.01% 2386
2023
Q4
Sell
-91,948
Closed -$1.22M 6736
2023
Q3
$1.22M Buy
+91,948
New +$1.48M ﹤0.01% 4025
2023
Q2
Sell
-28,679
Closed -$414K 6867
2023
Q1
$414K Buy
+28,679
New +$562K ﹤0.01% 4715
2022
Q4
Hold
0
7206
2022
Q3
Sell
-371,671
Closed -$11.9M 7647
2022
Q2
$5.68M Buy
+371,671
New +$5.76M 0.01% 2666
2021
Q3
Sell
-409,994
Closed -$24.7M 7358
2021
Q2
$24.7M Buy
+409,994
New +$17M 0.03% 1029

Other funds holding VERV